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Abstract
Background: We linked extensive longitudinal data from the Swedish national eating disorders quality registers
and patient registers to explore clinical characteristics at diagnosis, diagnostic flux, psychiatric comorbidity, and
suicide attempts in 850 individuals diagnosed with binge-eating disorder (BED).
Method: Cases were all individuals who met criteria for BED in the quality registers (N = 850). We identified 10 controls
for each identified case from the Multi-Generation Register matched on sex, and year, month, and county of birth. We
evaluated characteristics of individuals with BED at evaluation and explored diagnostic flux across eating disorders
presentations between evaluation and one-year follow-up. We applied conditional logistic regression models to assess
the association of BED with each comorbid psychiatric disorder and with suicide attempts and explored whether risk
for depression and suicide were differentially elevated in individuals with BED with or without comorbid obesity.
Results: BED shows considerable diagnostic flux with other eating disorders over time, carries high psychiatric
comorbidity burden with other eating disorders (OR 85.8; 95 % CI: 61.6, 119.4), major depressive disorder (OR 7.6; 95 %
CI: 6.2, 9.3), bipolar disorder (OR 7.5; 95 % CI: 4.8, 11.9), anxiety disorders (OR 5.2; 95 % CI: 4.2, 6.4), and post-traumatic
stress disorder (OR 4.3; 95 % CI: 3.2, 5.7) and is associated with elevated risk for suicide attempts (OR 1.8; 95 % CI: 1.2,
2.7). Depression and suicide attempt risk were elevated in individuals with BED with and without comorbid obesity.
Conclusions: Considerable flux occurs across BED and other eating disorder diagnoses. The high psychiatric
comorbidity and suicide risk underscore the severity and clinical complexity of BED.
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Background
Binge-eating disorder (BED), a recent addition to the
DSM-5 [1], is marked by recurrent episodes of binge
eating in the absence of recurrent inappropriate com-
pensatory behaviors. Global DSM-IV lifetime prevalence
estimates for BED are approximately 1.9 % in adults [2].
An internet-based study of 22,397 adults [Validate Atti-
tudes and Lifestyle Issues in Depression ADHD and
Troubles with Eating (VALIDATE)], reported lifetime
prevalence estimates of DSM-5 BED projected to the US
population to be 2.03 %, (1.41 % for men and 2.61 % for
women) [3]. Age at onset is typically late teens to early
twenties [2, 4]. The illness can be protracted and can
wax and wane [2, 4–8]. We explored fundamental fea-
tures of BED including clinical characteristics, diagnostic
flux, and psychiatric comorbidities, using rich, extensive,
Swedish population register data.
Diagnostic flux (i.e., migration from one eating disor-
ders presentation to another) commonly occurs between
anorexia nervosa (AN) and bulimia nervosa (BN) [5, 6, 8–
11]; however, less is known regarding flux in BED.
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Crossover between BED and BN [5, 6] and between BED
and eating disorder not otherwise specified (EDNOS) [5]
has been reported; however, large-scale, longitudinal,
population-based explorations are lacking.
Psychiatric comorbidity burden is considerable in indi-
viduals with BED with the most common co-occurring
conditions being mood [12–20], anxiety [13–20] and
substance use disorders [12, 14, 16, 17, 20]. Using na-
tional patient records, we are able to broaden the inquiry
to include more psychiatric disorders. An important
question addressed in the literature is the extent to
which morbidity and comorbidity in BED is attributable
to the presence of obesity. Hudson et al. [4] have shown
that risk for components of metabolic syndrome are
elevated in BED independent of the effects of BMI. We
further explored the extent to which observed psychi-
atric comorbidity in BED was attributable to obesity.
Register-based studies that include longitudinal follow-
up and that capture all clinical contacts in a nation’s
health care system allow for intensive characterization of
a disorder. By linking rich longitudinal data from the
Swedish national eating disorders quality registers and
national patient registers, we explored clinical character-
istics at evaluation, diagnostic flux, and psychiatric
comorbidity in all individuals presenting for evaluation
for BED across the country.
Methods
Procedure
Data were extracted in 2009 from Swedish population
registers, which can be linked via a unique personal
identification number assigned to all Swedish residents.
Specifically, we linked a) the eating disorders national
quality registers, Riksät-National Quality Register for Eat-
ing Disorders Treatment [21] and Stepwise [22] which
first entered patient information in 1999 and 2005; b) the
NPR [23], which provides national coverage of all Swedish
public and private hospital inpatient admissions beginning
in 1973 and outpatient specialist care beginning in 2001;
c) the Multi-Generation Register [24], which can be used
to determine biological and adoptive relationships for all
individuals living in Sweden since 1933; d) the Migration
Register [25]; and e) the Cause of Death Register [26],
which contains the date and principal and contributing
cause(s) of deaths since 1958. Details about the registers
are provided elsewhere [27]. Height and weight were
assessed at evaluation.
Informed consent is not required for inclusion in the
Swedish registers, except for Stepwise in which research
participation is elective [28]. The University of North
Carolina Biomedical Institutional Review Board and the
Regional Ethics Committee of Karolinska Institutet both
approved this study.
Sample
Cases were defined as any individual with a BED diagnosis
in Riksät [21] or Stepwise [22] at any evaluation point.
Briefly, Riksät is an Internet-based register for treatment
of eating disorders that includes eating disorders-specific
information on approximately 8,600 patients. Follow-up
assessments occur on a yearly basis as long as the patient
is in treatment. Eating disorder diagnoses are determined
at each assessment using standard clinical assessments
and BED is diagnosed specifically and not subsumed
under EDNOS.
All patients included in Stepwise are in Riksät, but the
reverse is not true. Stepwise contains more detailed in-
formation on clinical presentation, course, outcome, and
psychopathology. Once intent to treat is established
(usually within one to three weeks), eating disorders are
assessed by clinicians using structured diagnostic inter-
views assessing DSM-IV criteria [29]. Stepwise includes
initial data on approximately 2,700 eating disorders pa-
tients. Twelve-month follow-up data exist for ~69 % of
the patients registered in Riksät or Stepwise. Inclusion
criteria for Riksät and Stepwise are: a) medical or self-
referral to a participating treatment unit, b) a diagnosed
eating disorder, and c) intent to treat. Between them,
Riksät and Stepwise cover almost all specialized eating
disorder units in Sweden (in 2009 approximately 90 %),
and many non-specialized general psychiatric units.
We used the Multi-Generation Register to identify 10
controls for each case. Controls were matched to cases
based on sex, year and month of birth, and county of
birth. Cases born outside of Sweden were matched on
immigration status and time of migration (controls
could not immigrate later than their respective cases),
regardless of origin. Controls had to be alive and resi-
dent in Sweden for an equal period of time: from birth
or immigration up until the time of diagnosis for their
respective case. They also could not have received a
BED diagnosis in Riksät or Stepwise, but could have had
another eating disorder (detected in 1.0 % of controls).
Psychiatric diagnoses
Diagnostic information for psychiatric disorders and
suicide (see Table 1) for all cases and controls were ob-
tained from the NPR. Diagnoses were based on WHO
International Classification of Diseases, Ninth Revision
(ICD-9: years 1987–1996) or International Classification
of Diseases, Tenth Revision (ICD–10: years 1997–present).
Data analysis
Analyses were conducted using SAS version 9.4 [30]. We
first evaluated characteristics of individuals with BED at
the initial visit and explored diagnostic flux from the
initial visit to the first follow-up visit in individuals who
were diagnosed with BED at either of these occasions. We
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report diagnosis at evaluation and diagnosis at one-year
follow-up. Second, conditional logistic regression models
were applied to assess the association of BED status (case/
control) with each comorbid psychiatric disorder. Third,
given diagnostic flux, sensitivity analyses evaluating the
association between BED status and the psychiatric disor-
ders were conducted excluding cases (and their respective
controls) who had an additional eating disorder diagnosis
(other than BED) in Riksät or Stepwise or who had a diag-
nosis of AN or BN in the NPR. These sensitivity analyses
evaluated the association of BED and other psychiatric
disorders free from confounding of other detected eating
disorders. Sex differences in all models were explored. All
tests were two-tailed. Given reported associations between
obesity and depression and suicidality [31], we explored
whether obesity (BMI ≥ 30 kg/m2) was associated with in-
creased risk of depression and attempted suicide in indi-
viduals with BED while controlling for sex, and county
and year of birth.
Results
Sample description
A total of 850 individuals, (4.6 % male), were identified with
a diagnosis of BED. Table 2 presents the characteristics of
the BED sample at evaluation. The age range for first BED
diagnosis was 14–72 years (mode = 22 years). Men were
significantly older, had significantly higher BMIs, and were
more likely to be immigrants than women. The majority
(67 %) attended a follow-up registration for Riksät/Step-
wise, on average, 1.5 years after their initial visit.
Out of the 850 individuals, 807 (94.9 %) received their
BED diagnosis either at evaluation or one year follow-
up. The remaining 43 individuals were first diagnosed
with BED at a later follow-up. Figure 1 depicts the
changes in eating disorder diagnoses between the initial
visit and one year follow-up visit for these 807 individ-
uals. Of the 695 individuals diagnosed with BED at
evaluation, 279 (40.1 %) did not have a follow-up visit.
However, 170 (24.5 %) received a second BED diagnosis
at follow-up and 170 (24.5 %) received no eating dis-
order diagnosis at follow-up. In addition, 112 individuals
were diagnosed with AN, BN, or EDNOS at evaluation,
but received a diagnosis of BED at one-year follow-up.
Associations between BED and each psychiatric dis-
order in the full sample are presented in Table 3. BED
was significantly associated with all psychiatric disorders
evaluated except schizophrenia, schizoaffective disorder,
and autism, where power was too low to draw meaning-
ful conclusions. The strongest associations were with
other eating disorders, particularly BN, and the compos-
ite “any eating disorder” category. Of the other disorders,
major depressive disorder (MDD) and bipolar disorder
had the strongest associations with BED followed by any
anxiety disorder and post-traumatic stress disorder
(PTSD). Suicide risk, even after controlling for MDD,
was significantly elevated in individuals with BED. Sex
differences could not be evaluated for 11 disorders
because of small cell sizes, and no sex differences were
observed for any anxiety disorder, MDD, BN, and any
eating disorder.
Table 1 ICD-9 and ICD-10 codes for other psychiatric diagnoses from the National Patient Register
Diagnosis ICD9 ICD10
Schizophrenia 295A–295E, 295G, 295W, 295X F20, F20.0–F20.6, F20.8 F20.9
Schizoaffective disorder 295H F25, F25.0–F25.2, F25.8, F25.9, F23.1, F23.2
Bipolar disorder 296A, 296C–296H, 296W, 296X F30, F30.1, F30.2, F30.8, F30.9, F31, F31.0–F31.9, F34.0
Major depressive disorder 296B, 300E, 311 F32, F32.0–F32.3, F32.8, F32.9, F33, F33.0–F33.4, F33.8, F33.9, F34.1,
F34.8, F34.9, F38, F38.0, F38.1, F38.8, F39
Any anxiety disordera 300A, 300C F40, F40.0–F40.2, F40.8, F40.9, F41, F41.0–F41.3, F41.8, F41.9
Obsessive-compulsive disorder 300D F42, F42.0–F42.2, F42.8, F42.9
Post-traumatic stress disorder 308, 309A, 309B, 309W, 309X F43, F43.0–F43.2, F43.8, F43.9
Attention deficit hyperactivity disorder 314 J, 314W, 314X F90, F90.0, F90.1, F90.8
Autism 299A F84.0, F84.1, F84.5
Alcohol use disorder 303, 303A, 303X, 305A F10, F10.0–F10.9
Drug use disorder 304, 304A–304H, 304W, 304X, 305X F11, F11.0–F11.9, F12, F12.0–F12.9, F13, F13.0–F13.9, F14,
F14.0–F14.9, F15, F15.0–F15.9, F16, F16.0–F16.9, F18, F18.0–F18.9,
F19, F19.0–F19.9
Anorexia nervosa 307B F50.0, F50.1
Bulimia nervosa – F50.2, F50.3
Any eating disorder 307B, 307F F50.0–F50.5, F50.8, F50.9
Suicide attempts/completions E95A–E95H, E95W, E95X X60–X84
aAny anxiety disorder does not include obsessive-compulsive disorder or post-traumatic stress disorder
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Results from the sensitivity analyses, where cases with
other lifetime eating disorder diagnoses and their controls
were removed, are presented in Table 4. The associations
between BED and comorbid disorders remained signifi-
cant, with the exception of drug use disorder and suicide.
In addition, we compared comorbidity profiles in
individuals who returned for follow-up versus those who
did not. The only difference was a greater likelihood of
reporting alcohol use disorders in those who did not return
(data not shown).
Finally, the OR for MDD was significantly elevated in
individuals with BED with comorbid obesity, ONLY when
Table 2 Characteristics of BED cases at initial visit to clinic and results comparing men with women
All Women Men Statistical test: value (p-value)
Total Sample: N (%) 850 (100.0) 811 (95.4) 39 (4.6)
Received BED diagnoses only: N (%) 607 (71.4) 575 (70.9) 32 (82.1) χ2: 2.27 (.13)
Age at first visit: mode 22 22 25 t: 2.47 (.01)*
BMI: mean (std) 29.8 (8.4) 29.7 (8.3) 32.7 (9.4) t: 2.20 (.03)
At least one follow-up visit: N (%) 571 (67.2) 546 (67.3) 25 (64.1) χ2: 0.18 (.68)
Days to first follow-up visit: mean (std) 548.4 (411.6) 546.6 (413.8) 586.8 (365.0) t: 1.40 (.16)*
Immigrated: N (%) 73 (8.6) 66 (8.1) 7 (17.9) χ2: 4.56 (.03)
*Wilcoxon rank sum test
Fig. 1 Diagnostic flux in individuals with BED. The sample included only those individuals who received a diagnosis of BED at the initial visit or at first
follow-up visit. (Note: AN = anorexia nervosa, BN = bulimia nervosa, BED = binge-eating disorder, EDNOS = eating disorder not otherwise specified)
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Table 3 N (%) of individuals with each psychiatric disorder by BED group (case/control) and results of conditional logistic regressions
[OR (95 % CI)] evaluating the association of BED with each psychiatric disorder
BED (Cases) N = 850 Controls N = 8,500
N (%) N (%) OR (95 % CI)
Schizophrenia 1 (0.1) 17 (0.2) 0.6 (0.1, 4.7)
Schizoaffective disorder 1 (0.1) 10 (0.1) 1.1 (0.1, 8.8)
Bipolar disorder 35 (4.2) 49 (0.6) 7.5 (4.8, 11.9)
Major depressive disorder 203 (23.9) 337 (4.0) 7.6 (6.2, 9.3)
Any anxiety disordera 146 (17.2) 315 (3.7) 5.2 (4.2, 6.4)
Obsessive-compulsive disorder 10 (1.2) 37 (0.4) 2.6 (1.2, 5.5)
Post-traumatic stress disorder 80 (9.4) 209 (2.5) 4.3 (3.2, 5.7)
Attention deficit hyperactivity disorder 14 (1.7) 51 (0.6) 3.1 (1.7, 5.6)
Autism 2 (0.2) 27 (0.3) 0.4 (0.1, 3.0)
Alcohol use disorder 27 (3.2) 152 (1.8) 1.7 (1.1, 2.7)
Drug use disorder 18 (2.1) 94 (1.1) 1.9 (1.1, 3.2)
Anorexia nervosa 40 (4.7) 37 (0.4) 10.6 (6.7, 16.8)
Bulimia nervosa 96 (11.3) 11 (0.1) 99.9 (50.4, 198.3)
Any eating disorder 375 (44.1) 83 (1.0) 85.8 (61.6, 119.4)
Suicide attempts/completions 49 (5.8) 139 (1.6) 3.6 (2.5, 5.0)
Suicide attempts/completionsb 49 (5.8) 139 (1.6) 1.8 (1.2, 2.7)
aAny anxiety disorder does not include obsessive-compulsive disorder or post-traumatic stress disorder
bAfter controlling for the presence of major depressive disorder
Table 4 N (%) of individuals with each psychiatric disorder by BED group (case/control), excluding cases who received other eating
disorder diagnoses than BED and their controls, and results of conditional logistic regressions [OR (95 % CI)] evaluating the association of
BED with each psychiatric disorder
BED (Cases) N = 549 Controls N = 5,490
N (%) N (%) OR (95 % CI)
Schizophrenia 1 (0.2) 16 (0.3) 0.7 (0.1, 5.0)
Schizoaffective disorder 1 (0.2) 6 (0.1) 2.0 (0.2, 17.1)
Bipolar disorder 25 (4.6) 35 (0.6) 7.6 (4.4, 13.0)
Major depressive disorder 130 (23.7) 227 (4.1) 7.1 (5.6, 9.2)
Any anxiety disordera 93 (16.9) 205 (3.7) 5.0 (3.8, 6.5)
Obsessive-compulsive disorder 5 (0.9) 20 (0.4) 2.9 (1.0, 7.9)
Post-traumatic stress disorder 56 (10.2) 134 (2.4) 4.6 (3.3, 6.5)
Attention deficit hyperactivity disorder 11 (2.0) 35 (0.6) 3.5 (1.8, 7.1)
Autism 1 (0.2) 16 (0.3) 0.5 (0.0, 2.4)
Alcohol use disorder 18 (3.3) 95 (1.7) 1.9 (1.1, 3.2)
Drug use disorder 9 (1.6) 67 (1.2) 1.4 (0.7, 2.8)
Suicide attempts/completions 25 (4.6) 88 (1.6) 2.8 (1.8, 4.5)
Suicide attempts/completionsb 25 (4.6) 88 (1.6) 1.5 (0.9, 2.7)
aAny anxiety disorder does not include obsessive-compulsive disorder or post-traumatic stress disorder
bControlling for major depressive disorder
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including individuals who also had other lifetime eating
disorders. When confining the analyses to individuals who
ONLY had a BED diagnosis, there was no significant
elevation in MDD associated with comorbid obesity. The
risk of suicide attempts in individuals with BED with or
without comorbid obesity did not differ significantly.
Discussion
Using the extensive register data available for the entire
country of Sweden, we were afforded the unique oppor-
tunity to explore clinical course and psychiatric comor-
bidity of all individuals seeking treatment for BED,
yielding a sample of 850 individuals. Briefly, BED shows
considerable diagnostic fluidity with other eating disor-
ders, carries high psychiatric comorbidity burden, and is
associated with elevated suicide risk.
The reported age range at first diagnosis was broad
(from 14–72), encouraging vigilance for BED across the
age spectrum. Less than 5 % of the sample was male,
which could reflect a lower prevalence of BED in males
in Sweden (contrast the projected lifetime prevalence of
1.41 % projected for men in the US [3]), or, that males
with BED are less likely to seek assistance for their disor-
dered eating than females [32]. A recent evidence based
review reported that across 48 reviewed randomized
controlled trials, the percentage of females participating
ranged from 67 to 100 % [33] suggesting that relative to
epidemiological prevalence estimates, females do indeed
appear to be more likely to seek treatment. Therefore,
treatment seeking (not just in Sweden) may be less com-
mon in males with BED, underscoring the importance of
psychoeducation that reaches males as well as clinicians
and other positioned to detect BED in males.
Fortuitously, 67 % of evaluated individuals returned
for a follow-up visit allowing us to capture detailed clin-
ical course and symptom progression, although, by the
nature of the quality registers, we are unable to tether
those changes to specific interventions. One quarter of
the returnees received a second diagnosis of BED at
follow-up and one quarter received no eating disorder
diagnosis reflecting remission of symptoms. Sixteen
percent of those returning for follow-up received a dif-
ferent eating disorder diagnosis—most commonly BN or
EDNOS and occasionally AN. This novel observation is
of clinical importance in encouraging clinicians to be
mindful of signs of transitioning to other eating disorder
presentations. Those who transitioned to EDNOS may
have been on a recovery trajectory and the change in
diagnosis could reflect a reduction in total symptomatol-
ogy (e.g., binge frequency) reflecting a subthreshold
presentation. Such changes will presumably be rectified
with the inclusion of remission specifiers in DSM-5.
Transitions to BN and AN do not reflect a remission
trajectory, but rather reflect the emergence of recurrent
inappropriate compensatory behaviors (in BN) or signifi-
cant weight loss and/or restricting behaviors (in AN),
both concerning clinical developments. Of note, flux was
bidirectional, with patients also transitioning to BED
from AN, BN, or EDNOS. Given that our design only
included at maximum two visits, and also reported on
individuals who only made one visit to a clinic, although
we can describe considerable diagnostic flux, we are not
well positioned to comment authoritatively on the long-
term stability of BED as a diagnostic entity.
We confirm and extend previous reports of comorbid-
ity in BED [12–20]. The greatest lifetime comorbidity
burden was with the other eating disorders with the
large odds ratio dramatically highlighting the diagnostic
fluidity of these illnesses and encouraging further inves-
tigation into the mechanisms underlying diagnostic in-
stability. Genetic, neurobiological, and environmental
influences should be explored and risk algorithms devel-
oped to aid in the prediction of clinical course.
Of the other psychiatric disorders, the risk of MDD
and bipolar disorder were most elevated, followed by
anxiety disorders and PTSD. Only risk for schizophrenia,
schizoaffective disorder, and autism spectrum disorders
were not elevated. Elevated risk for depression was not
associated with comorbid obesity in the “pure BED” (i.e.,
no other eating disorder diagnoses) sample. Thus it
should not be assumed that normal weight individuals
with BED are at any less risk for depression. These
observations underscore the substantial comorbidity
burden carried by individuals with BED and highlight
the clinical importance of assessing and addressing the
full array of presenting problems facing these patients.
Treatment research should address the extent to which
interventions require tailoring based on comorbidity
profile.
Of particular clinical concern is the elevated risk for
suicide in individuals with BED. Even when controlling
for the presence of MDD, those with BED were at sig-
nificantly increased risk for suicide attempts. Our sensi-
tivity analyses revealed that suicide risk was elevated
regardless of the presence of comorbid obesity. These
results extend previous reports [34] and underscore the
seriousness of BED as a psychiatric illness.
Our observations of elevated suicide risk in BED are
important clinically; however, alternative designs are
necessary to explicate the mechanism of the association
[35]. One possibility is that a factor such as impulsivity
could represent a genetically influenced intermediate
phenotype behind both BED [36, 37] and some, but not
all forms of suicidal behavior [38–40]. Alternatively or
complementarily, environmental risk factors (e.g., sexual
and physical abuse, bullying or being bullied) could rep-
resent important shared risk factors for BED [41] and
suicidal behavior [42, 43].
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The comparison of individuals with pure BED versus
those with lifetime histories of other eating disorders re-
vealed similarly high comorbidity burden, with the excep-
tion of drug use and suicide. This observation suggests
that suicide risk in BED may be particularly concerning in
those who have transitioned to or from other eating disor-
ders during the trajectory of their illness.
Our study has notable limitations. First, we only in-
cluded individuals who presented for an evaluation and
received a diagnosis of BED. Untreated individuals in the
community may present with different patterns of clin-
ical course, comorbidity, and suicide risk. Second, we
did not screen for eating disorders in controls. As such,
our analyses represent conservative comparisons and the
actual associations may be stronger. This approach was
taken to guard against inflated estimates caused by artifi-
cially “clean” control samples. Third, as personality dis-
orders tend to be less reliably included in patient
registers, we were unable to explore comorbidity be-
tween BED and personality disorders. Fourth, assuming
variable and incalculable lags between symptom onset
and diagnosis across disorders, reports on the temporal-
ity of diagnoses could reflect either true order of onset
of the disorders or differential latency to treatment seek-
ing. Fifth, 33 % of patients did not return for follow-up.
With the exception of alcohol use disorders, their co-
morbidity profiles were no more severe. Those who did
not return may not have been recommended for further
treatment at a specialty service or could have opted out
of treatment.
Balancing these limitations are several methodological
strengths including the large sample size, standardized
evaluation by trained clinicians and the longitudinal
follow up afforded by the Swedish eating disorders qual-
ity registers, national healthcare records, and detailed
register-based patient psychiatric and other medical
history.
Conclusion
In conclusion, rich data from the Swedish registers on
850 individuals with BED reveal considerable diagnostic
fluidity across eating disorders presentations, high co-
morbidity burden, and elevated suicide risk. Clinicians
should remain vigilant for a broad array of comorbid
conditions, for the emergence of inappropriate compen-
satory behaviors or restrictive eating, and for suicidal
ideation in patients with BED.
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